Showing 2771-2780 of 19323 results for "".
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
https://reachmd.com/programs/global-womens-health-academy/more-than-womens-issues-womens-reproductive-and-gynaecological-health-and-work/9819/This article will review areas of women’s reproductive and gynaecological health, and shine light on what those mean in terms of the workplace.Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
https://reachmd.com/programs/cme/interdisciplinary-strategies-for-brca-mutated-ebc-testing-targeting-and-team-based-care/36606/Explore genetic testing, clinical trial evidence, and team-based strategies for managing patients with high-risk BRCA-mutated early-stage breast cancer.Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
https://reachmd.com/programs/cme/clinical-evidence-insights-from-early-trials-of-cdh6-targeted-therapies/37669/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerThe Impact of Hemophilia Across Patients’ Lives
https://reachmd.com/programs/cme/the-impact-of-hemophilia-across-patients-lives/35547/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
https://reachmd.com/programs/cme/considering-the-promise-of-new-and-emerging-treatments-for-hemophilia-the-need-for-iti/35551/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
https://reachmd.com/programs/cme/why-are-the-fetus-and-placenta-not-rejected-by-the-mother-new-insights-into-maternal-anti-fetal-rejection/13912/Have you thought about the fetus and placenta as transplants? Tune in to hear experts break down the mechanisms of maternal anti-fetal rejection.PROMs in Clinical Practice: Impacting Treatment Decisions
https://reachmd.com/programs/cme/proms-in-clinical-practice-impacting-treatment-decisions/33243/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
https://reachmd.com/programs/cme/patient-reported-outcome-measures-proms-valuable-insights-into-the-lived-experience-of-pah/33240/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Progressive Multiple Sclerosis: Functional, Anatomic, and Biologic Tools to Assess Disability Progression and Improve Patient Outcomes
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/progressive-multiple-sclerosis-functional-anatomic-and-biologic-tools-to-assess-disability-progression-and-improve-patient-outcomes/33143/An enhanced ability to quantify multiple sclerosis disease progression is key for timely optimization of treatment and risk mitigation of worsening disability.The Heritage of Platelet-Derived Growth Factor
https://reachmd.com/topics/regenerative-medicine/the-heritage-of-pdgf/48868/From its discovery nearly half a century ago to its current place in patient care and scientific conversation in aesthetic medicine, poorly healing skin wounds, orthopedics, and dental surgical reconstruction, platelet-derived growth factor (PDGF) stands as both a milestone of molecular biology and